Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of ...

National Cancer Institute, Singapore (NCIS), the Yong Loo Lin School of Medicine, National University of Singapore, Duke-NUS Medical School and National Cancer Centre Singapore (NCCS) unveil findings ...

Sarcomatoid carcinomas of the stomach are rare and carry a poor prognosis. Surgical resection remains the primary treatment, though recurrence rates are high, and survival is limited. Further research ...

In tandem with this breakthrough, a clinical trial has demonstrated the potential of an innovative treatment strategy ...

The clinical trial and a new study mark a significant leap in the fight against gastric cancer with peritoneal spread. Read ...

In December 2022, top model Bianca Balti underwent a bilateral mastectomy, which is the removal of both breasts, as a ...

Pamiparib is under clinical development by BeiGene and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase transition success ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

ALBANY – Assembly Minority Leader Will Barclay (R,C-Pulaski) today announced his legislation, A.8868, has been signed by Gov. Kathy Hochul to provide death benefits to the family of New York ...

Cobimetinib fumarate is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Peritoneal Cancer.

New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of ...